| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/24/2011 | US20110045064 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione |
| 02/24/2011 | US20110045063 Phosphate-binding magnesium salts and uses thereof |
| 02/24/2011 | US20110045062 Formulation |
| 02/24/2011 | US20110045058 Transfection reagent |
| 02/24/2011 | US20110045056 Hydrogel co-polymer composition and its uses, for example as a wound dressing |
| 02/24/2011 | US20110045050 Nanoemulsion formulations for direct delivery |
| 02/24/2011 | US20110045049 Immunomodulating compositions and methods of use |
| 02/24/2011 | US20110045041 Compositions and methods for the delivery of agents |
| 02/24/2011 | US20110045033 Combination of Itriglumide and Proton Pump Inhibitors in the Treatment of Gastrointestinal and Related Disorders |
| 02/24/2011 | US20110045032 Composition, formulations & kit for treatment of respiratory and lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| 02/24/2011 | US20110045029 Oral formulation for delivery of poorly absorbed drugs |
| 02/24/2011 | US20110045028 Sustained release preparation |
| 02/24/2011 | US20110045023 Recombinant RSV Virus Expression Systems And Vaccines |
| 02/24/2011 | US20110045015 Conjugated beta-1,3-linked glucans |
| 02/24/2011 | US20110045012 Anti-atheroma vaccine |
| 02/24/2011 | US20110045005 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 02/24/2011 | US20110044999 Il-32 modulators |
| 02/24/2011 | US20110044993 Method for the prevention and treatment of cancer by inhibition of gpvi |
| 02/24/2011 | US20110044991 Methods and compositions for treating lymphoma and myeloma |
| 02/24/2011 | US20110044983 Complement inhibitors as therapeutic agents for treatment of cancer |
| 02/24/2011 | US20110044973 Treatment of cystic disease with lysophosphatidic acid antagonists |
| 02/24/2011 | US20110044971 Method and composition for treating a seratonin receptor-mediated condition |
| 02/24/2011 | US20110044969 Antimicrobial Agents for the Treatment of Campylobacter Species in the Crop of a Bird |
| 02/24/2011 | US20110044967 Conjugates Comprising a Biodegradable Polymer and Uses Therefor |
| 02/24/2011 | US20110044965 L-citrulline for treating endothelial dysfunction and erectile dysfunction |
| 02/24/2011 | US20110044964 Plant-based omega chewable supplement |
| 02/24/2011 | US20110044956 Nell-1 enhanced bone mineralization |
| 02/24/2011 | US20110044953 Methods and Compositions for Localized Secretion of Anti-CTLA-4 Antibodies |
| 02/24/2011 | US20110044947 Methods of treating cardiac disorders |
| 02/24/2011 | US20110044943 Anti-Viral Compounds, Compositions, And Methods Of Use |
| 02/24/2011 | US20110044942 Methods of treatment for solid tumors |
| 02/24/2011 | US20110044941 Immunotherapy for reversing immune suppression |
| 02/24/2011 | US20110044940 Thiazole Carboxamide Derivatives and Their Use to Treat Cancer |
| 02/24/2011 | US20110044938 Tetrahydrobenzothiophene derivatives |
| 02/24/2011 | US20110044935 Compositions and methods for treating and preventing cardiomyopathy and heart disease |
| 02/24/2011 | US20110044931 Multi-conjugate of sirna and preparing method thereof |
| 02/24/2011 | US20110044930 Copolyhydroxyalkylglutamines functionalised with hydrophobic groups, and uses thereof, especially in therapeutics |
| 02/24/2011 | US20110044929 Formulations and methods for treatment of inflammatory diseases |
| 02/24/2011 | US20110044921 Substances and compositions for enhancing dna repair and methods of use |
| 02/24/2011 | US20110044918 Novel sulfamide derivatives and cosmetic use thereof |
| 02/24/2011 | US20110044917 Dental composition for treating peri-implantitis |
| 02/24/2011 | US20110044914 Cleaning compositions and methods |
| 02/24/2011 | US20110044913 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone hemi-fumarate |
| 02/24/2011 | US20110044911 Use of Functionalized Magnetic Nanoparticles in Cancer Detection and Treatment |
| 02/24/2011 | US20110044908 Methods and Compositions for Treating and Identifying Compounds to Treat Age-Related Macular Degeneration |
| 02/24/2011 | US20110044904 Crystal forms of 2--adenosine |
| 02/24/2011 | US20110044903 Methods for producing microbubbles |
| 02/24/2011 | US20110044902 Modulation of the Immune Response |
| 02/24/2011 | US20110044901 Novel compounds |
| 02/24/2011 | US20110044899 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| 02/24/2011 | US20110044898 Translocator protein ligands |
| 02/24/2011 | US20110044895 Methods and compositions for reducing stemness in oncogenesis |
| 02/24/2011 | US20110044893 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 02/24/2011 | US20110043832 Printed audio format and photograph with encoded audio |
| 02/24/2011 | US20110042247 Formulations of azacitidine and its derivatives |
| 02/24/2011 | DE20321830U1 Mittelkettige Triglyeride (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätischen Lebensmittel für Diabetiker Medium Triglyeride (MCT) to optimize the nutritional fatty acids spectrum in a dietetic foods for diabetics |
| 02/24/2011 | DE10251709C5 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3 |
| 02/24/2011 | DE102009038565A1 Spray container with a valve in a spray head, useful as a mouth spray e.g. for preventing prostate cancer and cystitis, comprises a composition comprising astaxanthin in a microencapsulated form |
| 02/24/2011 | DE102009038123A1 Substituierte (Thiazolyl-carbonyl)imidazolidinone und ihre Verwendung Substituted (thiazolyl-carbonyl) imidazolidinones and their use |
| 02/24/2011 | CA2774891A1 Vesicular formulations |
| 02/24/2011 | CA2772242A1 Broad spectrum preservation blends |
| 02/24/2011 | CA2771790A1 Forms of dexlansoprazole and processes for the preparation thereof |
| 02/24/2011 | CA2771699A1 Method of treating cancer |
| 02/24/2011 | CA2771646A1 Dna ligands for aflatoxin and zearalenone |
| 02/24/2011 | CA2771630A1 Therapeutic methods and compositions |
| 02/24/2011 | CA2771609A1 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | CA2771594A1 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors |
| 02/24/2011 | CA2771579A1 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | CA2771532A1 Heterocyclic compounds and uses thereof |
| 02/24/2011 | CA2771484A1 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | CA2771453A1 Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof |
| 02/24/2011 | CA2771445A1 Novel fxr (nr1h4) binding and activity modulating compounds |
| 02/24/2011 | CA2771432A1 Heterocyclic oxime compounds |
| 02/24/2011 | CA2771403A1 Quinoline derivative-containing pharmaceutical composition |
| 02/24/2011 | CA2771358A1 Drug delivery systems (wafer) for pediatric use |
| 02/24/2011 | CA2771308A1 Topical gels |
| 02/24/2011 | CA2771257A1 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | CA2771234A1 Substituted hydrazide compounds and use thereof |
| 02/24/2011 | CA2771228A1 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
| 02/24/2011 | CA2771190A1 Heat shock protein binding compounds, compositions, and methods for making and using same |
| 02/24/2011 | CA2771166A1 Alcoholic compositions having a lowered risk of acetaldehydemia |
| 02/24/2011 | CA2770766A1 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones |
| 02/24/2011 | CA2770762A1 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics |
| 02/24/2011 | CA2770454A1 Biaryl compounds and methods of use thereof |
| 02/24/2011 | CA2770355A1 Use of aerosolized antibiotics for treating chronic obstructive pulmonary disease |
| 02/24/2011 | CA2770341A1 Riboflavin based aerosol and use as placebo in trials |
| 02/24/2011 | CA2770178A1 A process for the synthesis of naratriptan |
| 02/24/2011 | CA2770162A1 Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof |
| 02/24/2011 | CA2768341A1 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazine derivatives |
| 02/24/2011 | CA2760802A1 Low frequency glatiramer acetate therapy |
| 02/23/2011 | EP2287613A2 Detection, monitoring and treatment of cancer |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287304A1 Novel treatment of patients after stent implantation or balloon dilatation and novel drug eluting stents |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287230A1 Docetaxel polymer derivative, method for producing same and use of same |
| 02/23/2011 | EP2287205A2 Photoreactive polysaccharide. photocrosslinked polysaccharide products, the method of making them and medical materials made therefrom |
| 02/23/2011 | EP2287204A1 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 02/23/2011 | EP2287192A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |